Systemic chemotherapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) in patients with high-grade mucinous carcinoma peritonei of appendiceal origin

Munoz-Zuluaga Carlos A.; King Mary Caitlin; Ledakis Panayotis; Gushchin Vadim; Sittig Michelle; Nieroda Carol; Zambrano-Vera Katherine; Sardi Armando

首页> 外文期刊>European Journal of Surgical Oncology: The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology >Systemic chemotherapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) in patients with high-grade mucinous carcinoma peritonei of appendiceal origin

【24h】

Systemic chemotherapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) in patients with high-grade mucinous carcinoma peritonei of appendiceal origin

机译：细胞导致手术前的全身化疗和高含量粘液癌腹膜腹膜患者的高温腹膜内化疗（CRS / HIPEC）

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background: The role of systemic chemotherapy (SC) before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) in appendiceal high-grade mucinous carcinoma peritonei (HGMCP) is controversial. We analyzed the effect of SC prior to CRS/HIPEC in HGMCP.

机译：背景：在阑尾高级粘液癌腹膜（HGMCP）中的细胞导致手术和高温腹膜化疗（CRS / HIPEC）之前的系统化疗（SC）的作用是有争议的。我们在HGMCP中分析了CRS / HIPEC之前SC的影响。

著录项

来源
《European Journal of Surgical Oncology: The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 》 |2019年第9期| 共9页
作者
Munoz-Zuluaga Carlos A.; King Mary Caitlin; Ledakis Panayotis; Gushchin Vadim; Sittig Michelle; Nieroda Carol; Zambrano-Vera Katherine; Sardi Armando;
展开▼
作者单位

Mercy Med Ctr Inst Canc Care 227 St Paul Pl Baltimore MD 21202 USA;

Mercy Med Ctr Inst Canc Care 227 St Paul Pl Baltimore MD 21202 USA;

Mercy Med Ctr Inst Canc Care 227 St Paul Pl Baltimore MD 21202 USA;

Mercy Med Ctr Inst Canc Care 227 St Paul Pl Baltimore MD 21202 USA;

Mercy Med Ctr Inst Canc Care 227 St Paul Pl Baltimore MD 21202 USA;

Mercy Med Ctr Inst Canc Care 227 St Paul Pl Baltimore MD 21202 USA;

Mercy Med Ctr Inst Canc Care 227 St Paul Pl Baltimore MD 21202 USA;

Mercy Med Ctr Inst Canc Care 227 St Paul Pl Baltimore MD 21202 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学 ;
关键词
Cytoreductive surgery; Hyperthermic intraperitoneal; chemotherapy; Appendiceal cancer; Systemic chemotherapy; Peritoneal neoplasms; Signet ring cells;

机译：细胞功能性手术;高温腹膜内;化疗;阑尾癌;全身化疗;腹膜肿瘤;标志圈细胞;

相似文献

外文文献
中文文献
专利

1. Systemic chemotherapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) in patients with high-grade mucinous carcinoma peritonei of appendiceal origin [J] . Munoz-Zuluaga Carlos A., King Mary Caitlin, Ledakis Panayotis, European Journal of Surgical Oncology: The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology . 2019 ,第9期

机译：细胞导致手术前的全身化疗和高含量粘液癌腹膜腹膜患者的高温腹膜内化疗（CRS / HIPEC）
2. The pre-operative neutrophil–lymphocyte ratio predicts overall and disease-free survival following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with pseudomxyoma peritonei of appendiceal origin [J] . Karan Rangarajan, Kandiah Chandrakumaran, Sanjeev Dayal, International journal of hyperthermia: The official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group . 2018 ,第5期

机译：术前嗜中性白细胞与淋巴细胞的比率可预测阑尾假性粘液瘤腹膜切除术（CRS）和腹膜高温化疗（HIPEC）后的总体生存率和无病生存率
3. The pre-operative neutrophil-lymphocyte ratio predicts overall and disease-free survival following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with pseudomxyoma peritonei of appendiceal origin [J] . Rangarajan Karan, Chandrakumaran Kandiah, Dayal Sanjeev, International journal of hyperthermia: The official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group . 2018 ,第5期

机译：术前中性粒细胞 - 淋巴细胞比率预测细胞源性手术（CRS）和高温腹膜内化疗（HIPEC）在阑尾症起源的患者中预测整体和无病的存活率
4. Efficacy of Intraperitoneal Perfusion Hyperthermic Chemotheraphy(CHIP)With Cisplatin Combined With Intraveuous Chemotherapy for Patients With Advanced Gastrointestinal Carcinoma [C] . The 3rd Asian congress on hyperthermic oncology and the 9th Chineses symposium on hyperthermic oncology . 2002

机译：腹腔灌注热化学疗法（CHIP）联合顺铂联合静脉化疗治疗晚期胃肠道癌的疗效
5. The Evolution of Hyperthermic Intraperitoneal Chemotherapy in The Setting of Advanced Ovarian Cancer [D] . Quindlen, Kevin J. 2019

机译：高温腹膜内化疗的演变在晚期卵巢癌的环境中
6. Perioperative Systemic Chemotherapy for Appendiceal Mucinous Carcinoma Peritonei Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy [O] . Aaron U. Blackham, Katrina Swett, Cathy Eng, -1

机译：细胞减少手术和高温腹膜内化疗治疗阑尾粘液性腹膜癌的围手术期全身化学疗法
7. The pre-operative neutrophil–lymphocyte ratio predicts overall and disease-free survival following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with pseudomxyoma peritonei of appendiceal origin [O] . Karan Rangarajan, Kandiah Chandrakumaran, Sanjeev Dayal, 2017

机译：术前中性粒细胞淋巴细胞比率预测阑尾血症瘤腹膜腹膜患者的细胞源性手术（CRS）和高温腹膜化疗（HIPEC）之后的总体和无病生存率

Systemic chemotherapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) in patients with high-grade mucinous carcinoma peritonei of appendiceal origin

摘要

著录项

相似文献

相关主题

期刊订阅